September 20, 2017 10:16 AM EDT
News Briefing

Ar­cus scores $305M re­gion­al de­vel­op­ment pact with Tai­ho; Shire, Sh­iono­gi tout PhI­II AD­HD study

Shehla Shakoor

Managing Director

⇨ Ter­ry Rosen’s Ar­cus Bio­sciences has scored a $35 mil­lion de­vel­op­ment deal with Tai­ho in ex­change for re­gion­al rights to its can­cer im­munother­a­pies. Hay­ward …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times